Robert M Watson

Title: The Innovations of Robert M. Watson

Introduction

Robert M. Watson is a notable inventor based in Berkeley, CA, with a significant contribution to the field of molecular biology. He holds a total of 9 patents, showcasing his innovative approaches to nucleic acid detection and analysis.

Latest Patents

Among his latest patents is the "Homogeneous Assay System," which describes a process for detecting a target nucleic acid using labeled oligonucleotides. This method utilizes the 5' to 3' nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotides from hybridized duplexes, thereby releasing labeled oligonucleotide fragments for detection. This process can be easily incorporated into a PCR amplification assay. Another significant patent is the "Process for Discrimination of Nucleic Acid Sequence Variants," which similarly employs labeled oligonucleotides and the 5' to 3' nuclease activity for effective nucleic acid detection.

Career Highlights

Robert has worked with prominent companies in the biotechnology sector, including Roche Molecular Systems, Inc. and Hoffmann-La Roche Inc. His work in these organizations has contributed to advancements in molecular diagnostics and research.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues such as David H. Gelfand and Pamela M. Holland, further enhancing the impact of his innovations in the field.

Conclusion

Robert M. Watson's contributions to molecular biology through his patents and collaborations highlight his role as a leading inventor in the industry. His innovative methods for nucleic acid detection continue to influence research and diagnostics.